Get the Stockscreener App
20.74
4.29%
-0.93
Kardigan Inc stock is traded at $20.74, with a volume of 157.63K.
It is down -4.29% in the last 24 hours and down -5.86% over the past month.
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
See More
Previous Close:
$21.67
Open:
$21.89
24h Volume:
157.63K
Relative Volume:
0.89
Market Cap:
$1.85B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.85%
1M Performance:
-5.86%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$20.60
$22.11
1-Week Range:
$20.60
$24.76
52-Week Range:
$19.83
$27.00
Kardigan Inc Stock (KARD) Company Profile
Compare KARD vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KARD
Kardigan Inc
|
20.74 | 1.85B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Kardigan Inc Stock (KARD) Latest News
Price to earnings ratio of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to earnings ratio of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June - MarketBeat
Hrtg Pv, L.p. Net Worth (2026) - GuruFocus
Kevin Anthony Kelly Net Worth (2026) - GuruFocus
Schf Cif 2024, L.p. Net Worth (2026) - GuruFocus
Keith Bryon Johnson Net Worth (2026) - GuruFocus
Kardigan, Inc.: Target Price Consensus and Analysts Recommendations | KARD | US4859251013 - marketscreener.com
Kardigan, Inc.: Revenue and Earnings Analysts Forecasts Revisions | KARD | US4859251013 - marketscreener.com
Kardigan (KARD) grants 20,706 RSUs tied to Perceptive-linked director pay - Stock Titan
KARD Initiated Coverage by TD Cowen -- Price Target Announced at $46 - GuruFocus
KARD News & Events - Intellectia AI
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com UK
KARD Initiated Coverage by Leerink Partners -- Rating Outperform - GuruFocus
Kardigan (KARD) Stock Forecast and Price Target 2026 $KARD - MarketBeat
Jefferies initiates Kardigan stock with buy rating on cardiology pipeline By Investing.com - Investing.com Nigeria
KARD Initiated Coverage by JP Morgan -- Price Target Set at $51. - GuruFocus
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Jefferies Initiates Kardigan at Buy With $40 Price Target - marketscreener.com
TD Cowen Initiates Kardigan(KARD.US) With Buy Rating, Announces Target Price $46 - Moomoo
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline By Investing.com - Investing.com India
JPMorgan initiates Kardigan stock with overweight on pipeline By Investing.com - Investing.com Nigeria
JPMorgan initiates Kardigan stock with overweight on pipeline - Investing.com UK
Jefferies initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com
Kardigan, Inc. Common Stock (NASDAQ: KARD) Share Price, KARD Stock News, KARD Share Price & Updates - Kalkine
CapEx per share of Kardigan, Inc. – NASDAQ:KARD - TradingView
Total common shares outstanding of Kardigan, Inc. – NASDAQ:KARD - TradingView
Average basic shares outstanding of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. Balance Sheet – BOATS:KARD - TradingView
Equity in earnings of Kardigan, Inc. – NASDAQ:KARD - TradingView
EBIT of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to earnings forward of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to sales forward of Kardigan, Inc. – NASDAQ:KARD - TradingView
Kardigan, Inc. Financial Statements – NASDAQ:KARD - TradingView
Enterprise value to revenue forward of Kardigan, Inc. – NASDAQ:KARD - TradingView
Enterprise value to EBITDA ratio of Kardigan, Inc. – NASDAQ:KARD - TradingView
EBITDA of Kardigan, Inc. – NASDAQ:KARD - TradingView
Basic earnings per share (basic EPS) of Kardigan, Inc. – NASDAQ:KARD - TradingView
Kardigan (KARD) Revenue BreakdownMain Composition - Moomoo
HRTG GPE, LLC Acquires Significant Stake in Kardigan Inc - GuruFocus
Kardigan (KARD) Stock Analysis Report | Financials & Insights - Benzinga
KARD Price History for Kardigan Stock - Barchart.com
KARDKardigan Inc Volatility & Greeks - Finviz
Latham Advises on Kardigan’s US$460 Million IPO - Legal Desire Media and Insights
HRTG entities report 16.9M shares in Kardigan (KARD) — 18.2% stake - Stock Titan
Kardigan (KARD) backer ARCH discloses 16.2% ownership stake post-IPO - Stock Titan
ARCH Venture Fund XIII Discloses Investment in Kardigan with 16.2% Stake - TradingView
We've developed a first-of-its-kind medicine to battle cardiovascular disease: Kardigan CEO - AOL.com
Kardigan (KARD) Stock Trends and Sentiment 2026 $KARD - MarketBeat
Perceptive Advisors’ Kardigan (KARD) stake tops 8% with IPO lock-up - Stock Titan
Kardigan(KARD) Stock Options Chain | Quotes & News - Moomoo
Kardigan Inc Stock (KARD) Financials Data
There is no financial data for Kardigan Inc (KARD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Kardigan Inc Stock (KARD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
| ARCH Venture Partners XIII, LL | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):